Rifaximin use sparks superbug concern

A new study has found that an antibiotic for liver disease patients could expose them to greater risk of a dangerous superbug An international team of researchers has found that the use of rifaximin, commonly prescribed for patients with liver disease, has led to the global emergence of an almost untreatable form of the antimicrobial